Methodist DeBakey Cardiology Associates.
Houston Methodist Hospital, Houston, Texas, US.
Methodist Debakey Cardiovasc J. 2024 Mar 14;20(2):81-93. doi: 10.14797/mdcvj.1331. eCollection 2024.
Ischemic heart disease (IHD) is the leading cause of morbidity and mortality in both genders; however, young women fare the worst, likely reflecting the more complex spectrum of IHD in women when compared to men. Substantial sex-based differences exist in the underlying risk factors, risk enhancers, presentation, diagnosis, and pathophysiology of IHD that are mainly attributed to the influence of female sex hormones. This article reviews the spectrum of IHD including obstructive epicardial coronary artery disease (CAD), myocardial infarction with no obstructive coronary artery disease, ischemia with no obstructive coronary artery disease, spontaneous coronary artery dissection, coronary microvascular dysfunction, vasospastic angina, and coronary thrombosis/embolism that occur in women throughout various stages of their life cycle. We aim to update clinicians on the diagnosis and management of these various types of IHD and highlight where further randomized controlled studies are needed to determine optimal treatment and inform guideline-directed medical therapy.
缺血性心脏病(IHD)是男女发病率和死亡率的主要原因;然而,年轻女性的情况最差,这可能反映了与男性相比,女性 IHD 的范围更复杂。在 IHD 的潜在风险因素、风险增强因素、表现、诊断和病理生理学方面存在显著的性别差异,这主要归因于女性性激素的影响。本文综述了 IHD 的范围,包括阻塞性心外膜冠状动脉疾病(CAD)、非阻塞性冠状动脉疾病性心肌梗死、非阻塞性冠状动脉疾病性缺血、自发性冠状动脉夹层、冠状动脉微血管功能障碍、痉挛性心绞痛和冠状动脉血栓/栓塞,这些疾病发生在女性的整个生命周期的各个阶段。我们旨在为临床医生提供这些不同类型的 IHD 的诊断和管理方面的最新信息,并强调需要进一步进行随机对照研究,以确定最佳治疗方法,并为指南指导的医学治疗提供信息。